Related Experiment Videos
Severe cutaneous hypersensitivity requiring permanent icodextrin withdrawal in a CAPD patient
G Queffeulou1, M Bernard, F Vrtovsnik
1Department of Nephrology and Dermatology, Hôpital Bichat, Paris, France.
Clinical Nephrology
|April 1, 1999
Summary
Severe skin reactions to icodextrin can occur in diabetic patients undergoing continuous peritoneal dialysis (CAPD). Stopping icodextrin treatment led to skin healing, highlighting this rare but important adverse event.
Area of Science:
- Nephrology
- Dermatology
- Pharmacology
Background:
- Continuous peritoneal dialysis (CAPD) is a treatment for kidney failure.
- Icodextrin is a glucose polymer used as a dialysis fluid osmotic agent.
- Diabetic patients have unique physiological considerations during dialysis.
Observation:
- A diabetic patient on CAPD developed a severe cutaneous hypersensitivity reaction.
- The reaction manifested as a widespread skin issue.
- The patient's condition required intervention to manage the adverse event.
Findings:
- Icodextrin was identified as the causative agent for the hypersensitivity.
- Discontinuation of icodextrin was essential for the resolution of the skin reaction.
- The patient experienced complete cutaneous recovery after icodextrin withdrawal.
Implications:
- Clinicians should consider icodextrin hypersensitivity in CAPD patients presenting with skin reactions.
- Early recognition and withdrawal of icodextrin can prevent prolonged adverse effects.
- This case underscores the importance of monitoring for rare adverse drug events in chronic dialysis patients.